FDA Investigating Link Between Semaglutide and Hair Loss, Suicidal Thoughts
The FDA is investigating whether semaglutide, the active ingredient in the weight loss drug Wegovy and diabetes medication Ozempic, may cause hair loss and suicidal thoughts.
The FDA's Adverse Event Reporting Systems (FAERS) received reports of patients experiencing hair loss, suicidal ideation, and instances of aspiration while using GLP-1 drugs like semaglutide.